Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value ($000): $385,373 (100.0% shares, 0.0% debt)

Holdings (8)

MDXG MIMEDX GROUP, INC. 46.1%

Value ($000) $177,623 Shares 19,480,519 Est. Cost $6.88 Unrealized 0.0%

— REVANCE THERAPEUTICS INC 24.6%

Value ($000) $94,714 Shares 3,342,047 Est. Cost $31.50 Unrealized —

AXGN AXOGEN INC 9.2%

Value ($000) $35,476 Shares 1,981,888 Est. Cost $4.01 Unrealized +266.6%

EYPT EYEPOINT PHARMACEUTICALS INC 7.2%

Value ($000) $27,576 Shares 4,190,921 Est. Cost $4.68 Unrealized 0.0%

TELA TELA BIO, INC. 5.8%

Value ($000) $22,188 Shares 1,475,293 Est. Cost $12.79 Unrealized +26.9%

— VENUS CONCEPT, INC. 5.6%

Value ($000) $21,483 Shares 12,417,856 Est. Cost $4.17 Unrealized —

MNOV MEDICINOVA INC 1.5%

Value ($000) $5,817 Shares 1,105,941 Est. Cost $2.95 Unrealized +94.3%

— CATALYST BIOSCIENCES INC 0.1%

Value ($000) $496 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MDXG	MIMEDX GROUP, INC.	19,480,519	$177,623	46.1%	$6.88	0.0%	COM	602496101
—	REVANCE THERAPEUTICS INC	3,342,047	$94,714	24.6%	$31.50	—	COM	761330109
AXGN	AXOGEN INC	1,981,888	$35,476	9.2%	$4.01	+266.6%	COM	05463X106
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$27,576	7.2%	$4.68	0.0%	COM NEW	30233G209
TELA	TELA BIO, INC.	1,475,293	$22,188	5.8%	$12.79	+26.9%	COM	872381108
—	VENUS CONCEPT, INC.	12,417,856	$21,483	5.6%	$4.17	—	COM	92332W105
MNOV	MEDICINOVA INC	1,105,941	$5,817	1.5%	$2.95	+94.3%	COM NEW	58468P206
—	CATALYST BIOSCIENCES INC	78,622	$496	0.1%	$7.36	—	COM NEW	14888D208